Santarus Inc.

Company Website

10590 W. Ocean Air Drive., Suite 200
San Diego, CA 92130

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Santarus Inc.

Market Cap as of 6/12/2015

Market Cap as of 7/03/2014

Market Cap as of 07/02/2013

$1,392,778,320

Market Cap as of 06/26/2012

$440,151,093

Market Cap as of 01/04/2012

$197,833,700

Market Cap as of 06/20/2011

$195,910,800

Market Cap as of 01/06/2011

$207,648,900

Exchange and Ticker Symbol

Nasdaq: SNTS

Fields of Research

Engages in acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists

Major Products

Mmetformin hydrochloride extended release tablets (Glumetza), bromocriptine mesylate tablets (CYCLOSET), omeprazole/sodium bicarbonate capsules and powder for oral suspension (Zegerid), Budesonide MMX, Rhucin, Rifamycin SV MMX, SAN-300

View all the companies in San Diego Publicly Traded Companies

Santarus Inc.

Market Cap as of 6/12/2015

Exchange

NASDAQ GS

Ticker

SNTS

Executives

Gerald Proehl (profile)

  • Chief Executive Officer
  • President

Similar Companies

In-Vitro Diagnostic Substance Manufacturing325413
IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES2835
Drugs and Druggists' Sundries Merchant Wholesalers424210
DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS' SUNDRIES5122
Pharmacies and Drug Stores446110
DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS' SUNDRIES5122
Cosmetics, Beauty Supplies, and Perfume Stores446120
DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS' SUNDRIES5122